Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q. We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-Mb interval on 10q. A microsatellite, DG10S478, within intron 3 of the transcription factor 7-like 2 gene (TCF7L2; formerly TCF4) was associated with type 2 diabetes (P = 2.1 x 10(-9)). This was replicated in a Danish cohort (P = 4.8 x 10(-3)) and in a US cohort (P = 3.3 x 10(-9)). Compared with non-carriers, heterozygous and homozygous carriers of the at-risk alleles (38% and 7% of the population, respectively) have relative risks of 1.45 and 2.41. This corresponds to a population attributable risk of 21%. The TCF7L2 gene product is a high mobility group box-containing transcription factor previously implicated in blood glucose homeostasis. It is thought to act through regulation of proglucagon gene expression in enteroendocrine cells via the Wnt signaling pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The majority of associated loci are linked to beta cells, supporting the idea that impaired beta cell function is critical to type 2 diabetes pathogenesis78,80.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“The first associated loci, in genes including TCF7L2, INSR, IRS1, GCK and KCNJ11 (refs.77,78), were originally identified by linkage or candidate gene studies, and since the turn of the century, increasing size and depth of genome-wide association studies have rapidly expanded the list of associated loci in type 2 diabetes to more than 250 with 400 independent signals79.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“unequivocal replications are so far limited to variants in just three genes: PPARG, KCNJ11 and TCF7L2 (2-4).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [4]
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“The prevalence of type 2 diabetes worldwide is 6% but is projected to rise over the next decade owing to increasing age of the population and surge of obesit”
BackgroundConvergence of Wnt, ß-Catenin, and Cadherin Pathways
Nelson, W. J., & Nusse, R. (2004) · Science · doi:10.1126/science.1094291 · Cited by 2,515 · cited 1×
“The β-catenin protein is also important for mediating cell adhesion through its binding of cadherin”
BackgroundThe common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G., Peters, P. J., & Clevers, H. (1998) · Nature Genetics · doi:10.1038/1270 · Cited by 1,581
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · cited 1×
“Similar to TCF7L2 , five of the six positionally cloned genes for the rare mendelian forms of type 2 diabetes, maturity-onset diabetes of the young (MODY), are transcription factor”
BackgroundAllele-Sharing Models: LOD Scores and Accurate Linkage Tests
Kong, A., & Cox, N. J. (1997) · The American Journal of Human Genetics · doi:10.1086/301592 · Cited by 979
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Cited by
Items 801–900 of 1,004
Diabetes: Is There a Future for Pharmacogenomics Guided Treatment?
Pearson, E. R. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1484 · Cited by 42
“The diabetes risk variant rs7903146, an intronic singlenucleotide polymorphism within the TCF7L2 gene has the largest genetic effect on population risk for diabetes to date.(34) This risk variant is associated with reduced beta- cell function and is thus a plausible candidate for altering glycemic response to sulfonyl…”
BackgroundBagchi, D. P., Li, Z., Corsa, C. A. S., Hardij, J., Mori, H., Learman, B. S., Lewis, K. T., Schill, R. L., Romanelli, S. M., & MacDougald, O. A. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.100992 · Cited by 39
“…association studies across diverse human populations have found strong correlations between polymorphisms in the canonical Wnt transcriptional effector TCF7L2 and susceptibility to type 2 diabetes [19 e 21]; indeed, TCF7L2 is one of the strongest risk loci for development of type 2 diabetes.”
Polygenic Contribution to Obesity: Genome-Wide Strategies Reveal New Targets
Körner, A., Kiess, W., Stumvoll, M., & Kovacs, P. (2008) · Frontiers of Hormone Research · doi:10.1159/000115335 · Cited by 38
Guan, W., Pluzhnikov, A., Cox, N. J., & Boehnke, M. (2007) · Human Heredity · doi:10.1159/000114164 · Cited by 47
Detection of Allelic Imbalance in Gene Expression Using Pyrosequencing®
Wang, H., & Elbein, S. C. (2007) · Humana Press eBooks · doi:10.1385/1-59745-377-3:157 · Cited by 38
Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin Signaling
Seo, M. H., Lee, J., Hong, S.-W., Rhee, E.-J., Park, S. E., Park, C. Y., Oh, K. W., Park, S. W., & Lee, W.-Y. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166913 · Cited by 37
Imamura, M., & Maeda, S. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14149 · Cited by 51
“In 2006, fi ve SNPs and a tetranucleotide repeat polymorphism (DG10S478) within TCF7L2 were reported to show a strong association with type 2 diabetes in three independent cohorts – Icelandic, Danish and USA 15 – through a classical linkage and positional cloning approach.”
BackgroundGenetics of type 2 diabetes in European populations
Qi, Q., & Hu, F. B. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2012.00224.x · Cited by 44
“The TCF7L2 gene encodes a transcription factor that is a crucial component of the Wnt signaling pathway and had not been considered as a candidate for T2D.(8) Current evidence indicates that TCF7L2 may confer T2D risk through impaired b-cell function and insulin secretion, incretin effects, and dysregulation of proglu…”
BackgroundFunctional analysis of TCF7L2 genetic variants associated with type 2 diabetes
Pang, D., Smith, A. J. P., & Humphries, S. E. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.12.012 · Cited by 42
Evaluation of Genome-wide Association Study-identified Type 2 Diabetes Loci in African Americans
Long, J., Edwards, T. L., Signorello, L. B., Cai, Q., Zheng, W., Shu, X.-O., & Blot, W. J. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws176 · Cited by 42
Individualized Therapy for Type 2 Diabetes: Clinical Implications of Pharmacogenetic Data
Mannino, G. C., & Sesti, G. (2012) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-012-0002-7 · Cited by 45
“of developing T2DM [171].”
BackgroundKong, X., Xing, X., Hong, J., Zhang, X., & Yang, W. (2016) · Medicine · doi:10.1097/md.0000000000003841 · Cited by 40
The hypothesis that Helicobacter pylori predisposes to Alzheimer’s disease is biologically plausible
Contaldi, F., Capuano, F., Fulgione, A., Cigliano, R. A., Sanseverino, W., Iannelli, D., Medaglia, C., & Capparelli, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-07532-x · Cited by 39
Wang, L., Liu, Q., Kitamoto, T., Hou, J., Qin, J., & Accili, D. (2019) · Diabetes · doi:10.2337/db18-1236 · Cited by 37
“TCF7L2 is contained within the main type 2 diabetes susceptibility locus identified inmultiple genome-wide association studies of different ethnic groups (37,38).”
BackgroundThe genetic side of type 2 diabetes – A review
Cuschieri, S. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.012 · Cited by 43
Sharma, P. R., Mackey, A. J., Dejene, E. A., Ramadan, J. W., Langefeld, C. D., Palmer, N. D., Taylor, K. D., Wagenknecht, L. E., Watanabe, R. M., Rich, S. S., et al. (2015) · Endocrinology · doi:10.1210/en.2015-1203 · Cited by 41
Franklin, C. S., Aulchenko, Y. S., Huffman, J. E., Vitart, V., Hayward, C., Polašek, O., Knott, S., Zgaga, L., Zemunik, T., Rudan, I., et al. (2010) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2010.00607.x · Cited by 37
Roses, A. D. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.153 · Cited by 39
Myles, S., Hradetzky, E., Engelken, J., Lao, Ó., Nürnberg, P., Trent, R. J., Wang, X., Kayser, M., & Stoneking, M. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201793 · Cited by 43
Genetic variants inTCF7L2andKCNJ11genes in a Greek population with polycystic ovary syndrome
CHRISTOPOULOS, P. F., Mastorakos, G. P., Gazouli, M., Panidis, D., Deligeoroglou, E., Katsikis, I., Papadias, K., Diamanti‐Kandarakis, E., & Creatsas, G. C. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802196379 · Cited by 39
“Recently, the rs7903146 variant in the gene encoding transcription factor 7-like 2 (TCF7L2) was shown to be strongly associated with T2DM in European populations [9,10].”
BackgroundDietary fat, genes and insulin sensitivity
López‐Miranda, J., Pérez‐Martínez, P., Marín, C., Fuentes, F. J., Delgado‐Lista, J., & Pérez‐Jiménez, F. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0138-1 · Cited by 43
Vaquero, A. R., Ferreira, N. E., Omae, S. V., Rodrigues, M. V., Teixeira, S. K., Krieger, J. E., & Pereira, A. C. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00030.2012 · Cited by 42
Association of rs12255372 in theTCF7L2 gene with type 2 diabetes mellitus: a meta-analysis
Wang, J., Zhang, J., Li, L., Wang, Y., Wang, Q., Zhai, Y., You, H., & Hu, D. (2013) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20132677 · Cited by 36
“Publication search A systematic search of the US National Library of Medicine’s PubMed, the Cochrane Library, and Embase databases was conducted for all genetic association studies on rs12255372 in the TCF7L2 gene and T2DM published from 2006 [when the initial study reporting the association between rs12255372 and T2D…”
BackgroundMethodInfluentialGene–Nutrient Interactions in the Metabolic Syndrome
Phillips, C. M., Tierney, A. C., & Roche, H. M. (2008) · Lifestyle Genomics · doi:10.1159/000112461 · Cited by 42
“These data indicate a major role for genetic susceptibility, whilst also emphasising the important role of the environment. In particular, trends in diet and physical activity, coupled with genetic susceptibility, must account for the recent and dramatic rise in the incidence of the MetS and T2DM, demonstrating the im…”
BackgroundA Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination
Garcin, C. L., & Habib, S. J. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-53150-2_15 · Cited by 43
Nguyen‐Tu, M., Martínez-Sánchez, A., Leclerc, I., Rutter, G. A., & Xavier, G. D. S. (2020) · Diabetologia · doi:10.1007/s00125-020-05292-4 · Cited by 44
Systems biology and its potential role in radiobiology
Feinendegen, L. E., Hahnfeldt, P., Schadt, E. E., Stumpf, M. P. H., & Voit, E. O. (2007) · Radiation and Environmental Biophysics · doi:10.1007/s00411-007-0146-8 · Cited by 37
“In fact, a number of genome-wide association studies have already leveraged the availability of high-throughput genotyping technologies to identify polymorphisms in genes that associate with diseases like age-related macular degeneration [74–76], diabetes [ 77 , 78], obesity [79], and cancer [80], to name just a few.”
BackgroundGjesing, A. P., Kjems, L., Vestmar, M. A., Grarup, N., Linneberg, A. R., Deacon, C. F., Holst, J. J., Pedersen, O. B., & Hansen, T. F. (2010) · Diabetologia · doi:10.1007/s00125-010-1940-4 · Cited by 38
“TCF7L2 spans a ~216 kb region on chromosome 10, and consists of 17 exons [9, 10].”
BackgroundUse of mouse models in studying type 2 diabetes mellitus
Lee, A. W. S., & Cox, R. D. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001729 · Cited by 36
Pharmacogenetics in type 2 diabetes: potential implications for clinical practice
Huang, C., & Florez, J. C. (2011) · Genome Medicine · doi:10.1186/gm292 · Cited by 44
“Polymorphisms in the transcription factor 7like 2 gene ( TCF7L2 ) harbor the strongest association with T2D reported to date, which is present in nearly all ethnic groups [39,40].”
BackgroundHow hormones mediate trade-offs in human health and disease
Bribiescas, R. G., & Ellison, P. T. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0007 · Cited by 40
Insights into obesity and diabetes at the intersection of mouse and human genetics
Kebede, M. A., & Attie, A. D. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.06.006 · Cited by 35
“Examples from human GWAS or linkage studies are: TSF7L2 and type 2 diabetes (19), SORT1 and LDL Kebede and Attie Page 3”
TCF7L2 Polymorphism, Weight Loss and Proinsulin∶Insulin Ratio in the Diabetes Prevention Program
McCaffery, J. M., Jablonski, K. A., Franks, P. W., Dagogo-Jack, S. E., Wing, R. R., Knowler, W. C., Delahanty, L. M., Dabelea, D., Hamman, R. F., Shuldiner, A. R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021518 · Cited by 35
“It is well established that the rs7903146 variant in the transcription factor 7-like 2 gene ( TCF7L2 ) is associated with type 2 diabetes (T2D) [1–4].”
Islet Structure and Function in the GK Rat
Portha, B., Lacraz, G., Chavey, A., Figeac, F., Fradet, M., Tourrel‐Cuzin, C., Homo‐Delarche, F., Giroix, M.-H., Bailbé, D., Gangnerau, M.-N., et al. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_21 · Cited by 36
“Interestingly, the gene encoding for transcription factor TCF7L2 is also located in this locus and has recently been identified as a candidate gene for T2D in humans [ 110 ].”
BackgroundChakkera, H. A., Hanson, R. L., Raza, S. M., DiStefano, J. K., Millis, M. P., Heilman, R. L., Mulligan, D. C., Reddy, K. S., Mazur, M. J., Hamawi, K., et al. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.08.063 · Cited by 39
Turki, A., Al-Zaben, G. S., Mtiraoui, N., Marmmuoch, H., Mahjoub, T., & Almawi, W. Y. (2012) · Gene · doi:10.1016/j.gene.2012.10.086 · Cited by 35
R-spondin-1 Is a Novel β-Cell Growth Factor and Insulin Secretagogue
Wong, V. S. C., Yeung, A., Schultz, W., & Brubaker, P. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.129874 · Cited by 35
MiR-184 regulates insulin secretion through repression of Slc25a22
Morita, S., Horii, T., Kimura, M., & Hatada, I. (2013) · PeerJ · doi:10.7717/peerj.162 · Cited by 35
Greenawalt, D. M., Sieberts, S. K., Cornelis, M. C., Girman, C. J., Zhong, H., Yang, X., Guinney, J., Qi, L., & Hu, F. B. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws123 · Cited by 39
Genetic etiology of type 2 diabetes mellitus: a review
Kommoju, U. J., & Reddy, B. M. (2011) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-011-0020-8 · Cited by 41
Ali, S., Chopra, R., Manvati, S., Singh, Y. P., Kaul, N., Behura, A., Mahajan, A., Sehajpal, P. K., Gupta, S., Dhar, M. K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058881 · Cited by 35
Redondo, M. J., Muniz, J., Rodriguez, L. M., Iyer, D., Vaziri-Sani, F., Haymond, M. W., Hampe, C. S., Metzker, M. L., Grant, S. F. A., & Balasubramanyam, A. (2014) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2013-000008 · Cited by 34
Self-citationFOXN3 Regulates Hepatic Glucose Utilization
Karanth, S., Zinkhan, E. K., Hill, J. T., Yost, H. J., & Schlegel, A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.056 · Cited by 37
“…the most strongly associated diabetes gene TCF7L2, it is quite likely that extra-hepatic functions of FOXN3 in regulating aspects of glucose homeostasis exist (Boj et al., 2012; Dayeh et al., 2014; Grant et al., 2006; Lyssenko et al., 2007; van Es et al., 2012; van Vliet-Ostaptchouk et al., 2007).”
BackgroundREDONDO, M. J., Steck, A. K., Sosenko, J. M., Anderson, M. S., Antinozzi, P. A., Michels, A. W., Wentworth, J. M., Atkinson, M. A., Pugliese, A., Geyer, S. M., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0861 · Cited by 36
“risk allele (3), and have been functionally linked to impaired insulin secretion, defects in incretin- and glucose-induced glucagon suppression, abnormal insulin processing, and increased hepatic glucose release during fasting (4–6).”
BackgroundSequence variation at ANAPC1 accounts for 24% of the variability in corneal endothelial cell density
Ivarsdottir, E. V., Benónísdóttir, S., Þorleifsson, G., Sulem, P., Oddsson, Á., Styrkársdóttir, U., Kristmundsdóttir, S., Arnadottir, G. A., Þorgeirsson, G., Jónsdóttir, I., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09304-9 · Cited by 34
Secreted frizzled‐related protein 4 and its implication in obesity and type‐2 diabetes
Bukhari, S. A., Yasmin, A., Zahoor, M. A., Mustafa, G., Sarfraz, I., & Rasul, A. (2019) · IUBMB Life · doi:10.1002/iub.2123 · Cited by 37
“Development of mature adipocytes from precursor cells can be controlled by these inhibitors to eradicate obesity,65 T2D and other related metabolic disorders with elevated SFRP4 levels.42 Early detection of biomarkers of β-cell dysfunction in high risk individuals could help to target development of T2D.”
BackgroundInfluentialTian, L., Shao, W., Ip, W., Song, Z., Badakhshi, Y., & Jin, T. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000444 · Cited by 34
Genetic architecture of complex traits and disease risk predictors
Yong, S. Y., Raben, T. G., Lello, L., & Hsu, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-68881-8 · Cited by 38
Current progress in metabolomics of gestational diabetes mellitus
Wang, Q., You, L., Xiang, L.-L., Zhu, Y., & Zeng, Y. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i8.1164 · Cited by 37
Mahboob, A., Senevirathne, D. K. L., Paul, P., Nabi, F., Khan, R. H., & Châari, A. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.11.038 · Cited by 39
Individualized Weight Management: What Can Be Learned from Nutrigenomics and Nutrigenetics?
Rudkowska, I., & Përusse, L. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-398397-8.00014-9 · Cited by 38
“modulated by obesity.(108,109) Two studies have investigated the impact of TCF7L2 on weight management.”
BackgroundHu, C., Jia, W., Zhang, R., Wang, C., Lu, J., Wu, H., Fang, Q., Ma, X., & Xiang, K. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02314.x · Cited by 37
Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk
Hazra, A., Fuchs, C. S., Chan, A. T., Giovannucci, E. L., & Hunter, D. J. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9164-3 · Cited by 34
“The authors suggest that the TCF7L2 variants increase T2D risk by altering proglucagon gene expression [6] in enteroendrocrine cells [24] via the Wnt signaling pathway [26].”
BackgroundReplication of TCF7L2 rs7903146 association with type 2 diabetes in an Iranian population
Amoli, M. M., Amiri, P., Tavakkoly‐Bazzaz, J., Charmchi, E., Hafeziyeh, J., Keramatipour, M., Abiri, M., Ranjbar, S. H., & Larijani, B. A. (2010) · Genetics and Molecular Biology · doi:10.1590/s1415-47572010005000056 · Cited by 34
“…association between type 2 diabetes and a microsatellite marker located within intron 3 of the transcription factor 7-like 2 gene (TCF7L2) locus (Grant et al., 2006), a single nucleotide polymorphism (SNP) (rs7903146 allele T) within this gene was found to be in linkage disequilibrium with the…”
InfluentialTilg, H., & Moschen, A. R. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833a87cc · Cited by 37
Wu, C., & Cui, Y. (2013) · Human Genetics · doi:10.1007/s00439-013-1350-z · Cited by 36
“The causal genetic association between SNPs of the gene and the type 2 diabetes was first reported in Grant et al. (2006) and was subsequently replicated in many ethnic groups (Jin and Liu 2008).”
BackgroundInfluentialKakehashi, A., Стефанов, В. Е., Ishii, N., Okuno, T., Fujii, H., Kawai, K., Kawada, N., & Wanibuchi, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020434 · Cited by 36
“Transcription factor TCF7L2, involved in Wnt signaling, has been reported to play an important role and to be one of the risk factors in type 2 diabetes [56,57].”
BackgroundGenetic Variation and Human Aging: Progress and Prospects
Melzer, D. R., Hurst, A. J., & Frayling, T. M. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.3.301 · Cited by 35
Lifestyle Factors and Genetic Variants Associated to Health Disparities in the Hispanic Population
Fernández, M. L. (2021) · Nutrients · doi:10.3390/nu13072189 · Cited by 41
“In genome-wide association studies (GWAS), the transcription factor-7 like 2 gene (TCF7L2) was the first locus associated to type 2 diabetes [42].”
BackgroundGenome wide association studies for diabetes: perspective on results and challenges
Torres, J., Cox, N. J., & Philipson, L. H. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12015 · Cited by 33
Animal Models of GWAS-Identified Type 2 Diabetes Genes
Xavier, G. D. S., Bellomo, E. A., Mcginty, J. A., French, P. M. W., & Rutter, G. A. (2013) · Journal of Diabetes Research · doi:10.1155/2013/906590 · Cited by 35
“In recent years, the product of the TCF7L2 gene has been associated with dysregulated pancreatic β cell function and T2D [25, 27, 28].”
BackgroundInvestigating GSTT1 and GSTM1 null genotype as the risk factor of diabetes type 2 retinopathy
Dadbinpour, A., Sheikhha, M. H., Darbouy, M., & Afkhami‐Ardekani, M. (2013) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-12-48 · Cited by 34
“GSTs are dimeric proteins that catalyze conjugation reactions between glutathione and tobacco smoke substrates, such as aromatic heterocyclic radicals and epoxides [13-15].”
BackgroundGenome‐wide association studies (GWAS): impact on elucidating the aetiology of diabetes
Hakonarson, H. H., & Grant, S. F. A. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1221 · Cited by 36
“2 TCF7L2 Transcription factor-7-like 2 [68] 11p15.”
BackgroundSelf-citationPharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents
Pearson, E. R., Dawed, A. Y., & Zhou, K. (2016) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s84854 · Cited by 49
“Reduced insulin secretion has been reported in relation to two intronic variants, rs7903146 and rs12255372, in the TCF7L2 gene and hence hypothesized to affect SU response.(80) GoDARTs is the largest study conducted on 901 Scottish patients to link TCF7L2 variants with SU response.”
Progress in defining the genetic contribution to type 2 diabetes susceptibility
Morris, A. P. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.02.003 · Cited by 36
Li, Q., Hua, Y., Yang, Y., He, X., Zhu, W. P., Wang, J., & Gan, X. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00562-17 · Cited by 35
“Omics” and “epi-omics” underlying the β-cell adaptation to insulin resistance
Jesus, D. F. D., & Kulkarni, R. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.003 · Cited by 36
“In the early 2000s, the first linkage analyses and candidate approaches confirmed and identified several new genes associated with T2D, including PPARG [24] and TCFL2 [25].”
BackgroundZhang, Q., Fan, H., Liu, H., Jin, J., Zhu, S., Zhou, L. Q., Liu, H., Zhang, F., Zhan, P., Lv, T., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1071-4 · Cited by 37
Chapter 19 Role of Wnt Signaling in the Development of Type 2 Diabetes
Bordonaro, M. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00619-5 · Cited by 37
Cormier, H., Vigneault, J., Garneau, V, Tchernof, A., Vohl, M., Weisnagel, S., & Robitaille, J. (2015) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12937 · Cited by 34
Omori, S., Tanaka, Y., Horikoshi, M., Takahashi, A., Hara, K., Hirose, H., Kashiwagi, A., Kaku, K., Kawamori, R., Kadowaki, T., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1397-5 · Cited by 38
“Following the discovery of the transcription factor 7-like 2 gene (TCF7L2) as a strong susceptibility gene for type 2 diabetes [2], genome-wide association studies (GWASs) conducted by several independent European and American research groups have identified multiple susceptibility loci for type 2 diabetes in populati…”
BackgroundInfluentialHo, M. M., Yoganathan, P., Chu, K. Y., Karunakaran, S., Johnson, J. D., & Clee, S. M. (2013) · BMC Genetics · doi:10.1186/1471-2156-14-10 · Cited by 41
“The association between variants in TCF7L2 and type 2 diabetes, which was identified initially in pre-GWAS studies, has been almost universally replicated and has the largest effect on diabetes risk [19,20].”
BackgroundHHEX gene polymorphisms are associated with type 2 diabetes in the Dutch Breda cohort
van Vliet‐Ostaptchouk, J. V., Onland‐Moret, N. C., van Haeften, T. W., Franke, L., Elbers, C. C., Shiri‐Sverdlov, R., van der Schouw, Y. T., Hofker, M. H., & Wijmenga, C. (2008) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5202008 · Cited by 38
Schwab, C. R., Mote, B. E., Du, Z. ‐., Amoako, R., Baas, T. J., & Rothschild, M. F. (2009) · Journal of Animal Breeding and Genetics · doi:10.1111/j.1439-0388.2008.00770.x · Cited by 33
THE GENETICS OF TYPE 2 DIABETES MELLITUS : A REVIEW
Singh, S. (2011) · Cited by 42
Adipose- and muscle-derived Wnts trigger pancreatic β-cell adaptation to systemic insulin resistance
Koziński, K., Jazurek, M., Dobrzyń, P., Janikiewicz, J., Kolczyńska, K., Gajda, A., & Dobrzyń, A. (2016) · Scientific Reports · doi:10.1038/srep31553 · Cited by 33
Wnt Pathway in Pancreatic Development and Pathophysiology
Napolitano, T., Silvano, S., Ayachi, C., Plaisant, M., de Veiga, A. S., Fofo, H., Charles, B., & Collombat, P. (2023) · Cells · doi:10.3390/cells12040565 · Cited by 41
Sekar, P., Ventura, E. F., Dhanapal, A. C. T. A., Cheah, E. S. G., Loganathan, A., Quen, P. L., Appukutty, M., Taslim, N. A., Hardinsyah, H., Noh, M. F. M., et al. (2023) · Nutrients · doi:10.3390/nu15132948 · Cited by 40
“When the FTO gene is overexpressed in INS-1 pancreatic beta cells, it upregulates transcription factor 7-like 2 (TCF7L2) which is a key determinant of diabetes [60].”
BackgroundTsai, M.-K., Wang, H., Shiang, J.-C., Chen, I.-H., Wang, C.-C., Shiao, Y.-F., Liu, W., Lin, T.-J., Chen, T.-M., & Chen, Y.-H. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/650393 · Cited by 34
Association betweenTCF7L2Genotype and Glycemic Control in Diabetic Patients Treated with Gliclazide
Javorský, M., Babjaková, E., Klimčáková, L., Schroner, Z., Židzik, J., Štolfová, M., Salagovic, J., & Tkáč, I. (2013) · International Journal of Endocrinology · doi:10.1155/2013/374858 · Cited by 34
“The risk of developing diabetes is twice as high as that in homozygous carriers of the risk genotypes in comparison with homozygous carriers of common variants [7, 8].”
BackgroundTam, C. H. T., Ho, J. S. K., Wang, Y., Lam, V. K. L., Lee, H. M., Jiang, G., Lau, E. S. H., Kong, A. P. S., Fan, X., Woo, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083093 · Cited by 34
“The association of KCNQ1 rs2237892 was the strongest (P,8.5610218) while TCF7L2 rs7903146 showed the largest effect (OR [95% CI] = 2.09 [1.63– 2.69]), albeit with rare allele frequency (0.034 in T2D patients; 0.019 in healthy controls).”
BackgroundInfluentialSelf-citationExendin-4 upregulates the expression of Wnt-4, a novel regulator of pancreatic β-cell proliferation
Heller, C., Kühn, M. C., Mülders-Opgenoorth, B., Schott, M., Willenberg, H. S., Scherbaum, W. A., & Schinner, S. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00144.2011 · Cited by 32
“This pathway has attracted broad attention in diabetes research because TCF7L2, a transcription factor regulated by Wnt/ catenin, has been identified as the strongest susceptibility gene for type 2 diabetes mellitus in numerous populations (2, 5).”
BackgroundDiabetes Mellitus: Channeling Care through Cellular Discovery
Maiese, K., Shang, Y., Chong, Z. Z., & Hou, J. (2010) · Current Neurovascular Research · doi:10.2174/156720210790820217 · Cited by 34
Barboza, A. B. C., Winham, S. J., McElroy, S. L., Geske, J. R., Jenkins, G. D., Colby, C. L., Prieto, M. L., Ryu, E., Cunningham, J. M., Frye, M. A., et al. (2016) · Bipolar Disorders · doi:10.1111/bdi.12368 · Cited by 37
“Similar to our findings, GWASs suggest that the genetic risk of T2D and related metabolic traits are also influenced by BMI (17).”
BackgroundInfluentialThe role of transcription factor 7‐like 2 in metabolic disorders
Zhang, Z., Xu, L. L., & Xu, X. (2020) · Obesity Reviews · doi:10.1111/obr.13166 · Cited by 35
“The interaction between TCF7L2 SNPs and diet can affect the risk of T2D.”
BackgroundInfluentialRiedmaier, A. E., Schaeffeler, E., Nies, A. T., Mörike, K., & Schwab, M. G. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12330 · Cited by 39
Kifagi, C., Makni, K., Boudawara, M., Mnif, F., Hamza, N., Abid, M., Granier, C., & Ayadi, H. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0199 · Cited by 39
“Replicated associations were reported for SNPs in or near the genes TCF7L2 (transcription factor 7-like 2), SLC30A8 , IGF2BP2 , CDKN2A/2B , CDKAL1 , HHEX-IDE , EXT2 , LOC387761 , and FTO (Saxena et al. , 2007; Scott et al. , 2007; Sladek et al. , 2007; Steinthorsdottir et al. , 2007; Wellcome Trust Case Control Consor…”
InfluentialLangberg, K. A., Ma, L., Sharma, N. K., Hanis, C. L., Elbein, S. C., Hasstedt, S. J., & Das, S. K. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.133 · Cited by 33
Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes
Weyrich, P., Stefan, N., Häring, H., Laakso, M., & Fritsche, A. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0134-5 · Cited by 35
Nanfa, D., Sobngwi, E., Atogho‐Tiedeu, B., Noubiap, J. J., Donfack, O. S., Mato, E. P. M., Guewo‐Fokeng, M., Nguimmo-Metsadjio, A., Ngwa, E. N., Pokam, P. F., et al. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0058-1 · Cited by 39
“An association study reported a relationship between a common micro-satellite (DG10S478) in intron 3 of the TCF7L2 gene and T2DM [8].”
BackgroundChang, T., Chiu, Y., Sheu, W. H., Shih, K., Hwu, C., Quertermous, T., Jou, Y., Kuo, S., Chang, Y., & Chuang, L. (2015) · Scientific Reports · doi:10.1038/srep14380 · Cited by 36
Association between TCF 7L2 polymorphisms and gestational diabetes mellitus: A meta‐analysis
Chang, S., Wang, Z., Wu, L., Lü, X., Shangguan, S., Xin, Y., Li, L., & Wang, L. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12612 · Cited by 38
Hoffmann, K., Mattheisen, M., Dahm, S., Nürnberg, P., Roe, C., Johnson, J., Cox, N. J., Wichmann, H. ‐., Wienker, T. F., Schulze, J., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0658-4 · Cited by 32
“Similarly, we found no evidence for linkage to the region around DG10S478, where compelling associations with type 2 diabetes in Icelandic, Danish and US cohorts have been reported [ 25 ].”
BackgroundGenome-Wide Linkage Scan of Common Stroke in Families From Northern Sweden
Nilsson-Ardnor, S., Janunger, T., Wiklund, P.-G., Lackovic, K., Nilsson, A. K., Lindgren, P., Escher, S. A., Stegmayr, B., Asplund, K., & Holmberg, D. (2006) · Stroke · doi:10.1161/01.str.0000251643.37454.16 · Cited by 32
Association of a common variant in TCF7L2 gene with type 2 diabetes mellitus in a Persian population
Palizban, A., Nikpour, M., Salehi, R., & Maracy, M. R. (2011) · Clinical and Experimental Medicine · doi:10.1007/s10238-011-0144-7 · Cited by 34
Gattu, A. K., Birkenfeld, A. L., Iwakiri, Y., Jay, S. M., Saltzman, W. M., Doll, J. A., Protiva, P., Samuel, V. T., Crawford, S. E., & Chung, C. (2014) · Endocrinology · doi:10.1210/en.2013-1785 · Cited by 33
Acute Wnt pathway activation positively regulates leptin gene expression in mature adipocytes
Chen, Z., Shao, W., Xu, F. L., Liu, L., Lin, B., Wei, X., Song, Z., Lu, H., Fantus, I. G., Weng, J., et al. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.12.012 · Cited by 32
The multi-systemic nature of diabetes mellitus: Genotype or phenotype?
Ewing, G. W., & Syed, P. (2010) · North American Journal of Medical Sciences · doi:10.4297/najms.2010.2444 · Cited by 38
“Circa 25 genetic loci have been associated with NIDDM e.g. a mutation in the beta-3-adrenergic-receptor gene [16], variant of transcription factor 7-like 2 (TCF7L2) gene [17] (n.b. purely as a result of nucleotide variation within TCF7L2), etc.”
BackgroundFrom Genetic Association to Molecular Mechanism
van de Bunt, M., & Gloyn, A. L. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0150-2 · Cited by 37
“The approaches that can be taken to decipher the biological pathways involved are best illustrated by describing the efforts that have been made to elucidate the biology of FTO, TCF7L2, and G6PC2.”
BackgroundInfluentialPourahmadi, M., Erfanian, S., Moradzadeh, M., & Jahromi, A. S. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.6.512 · Cited by 34
“Risk alleles of these genes are associated with dysfunction in pancreatic β-cells in all subjects [11].”
BackgroundInfluential
Metadata
- Authors
- Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., Styrkarsdottir, U., Magnusson, K. P., Walters, G. B., Palsdottir, E., Jonsdottir, T., Gudmundsdottir, T., Gylfason, A., Saemundsdottir, J., Wilensky, R. L., Reilly, M. P., Rader, D. J., Bagger, Y., Christiansen, C., Gudnason, V., Sigurdsson, G., Thorsteinsdottir, U., Gulcher, J. R., Kong, A., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- National University Hospital of Iceland (IS)
- University of Pennsylvania (US)
- Center for Clinical & Basic Research (DK)
- Icelandic Heart Association (IS)
- Corresponding author
- Grant, Struan F A
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-01-15
- Volume
- 38
- Issue
- 3
- Pages
- 320-323
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1965141016
- Cited by
- 2,287
- References
- 25
- Citations by year
- 2026: 45 · 2025: 58 · 2024: 54 · 2023: 56 · 2022: 80 · 2021: 86 · 2020: 76 · 2019: 86 · 2018: 86 · 2017: 85 · 2016: 99 · 2015: 109 · 2014: 125 · 2013: 125 · 2012: 156
- FWCI
- 127.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- University of Pennsylvania
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, TCF7L2, transcription factor 7-like 2, chromosome 10q, genetic susceptibility, blood glucose homeostasis, Wnt signaling, Icelandic population, Danish population, United States population
- MeSH terms
- Chromosome Mapping, Chromosomes, Human, Pair 10, Denmark, Diabetes Mellitus, Type 2, Gene Frequency, Genetic Carrier Screening, Humans, Introns, Molecular Sequence Data, Reference Values, Cohort Studies, Microsatellite Repeats, Genetic Predisposition to Disease, TCF Transcription Factors, Transcription Factor 7-Like 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.